Dermanostic, a German company based in Düsseldorf, is facing an ongoing legal challenge over the risk classification of its teledermatology software platform from competitor company, Online Doctor 24 but has so far been successful in defending its case.
Dermanostic has classified its product as a low-risk class I device in the context of the Medical Device Regulation....
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?